相关实验视频
Updated: May 23, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
高风险HPV瘤蛋白和PD-1/PD-L1的相互作用
Shuai Zhen1,2
1Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, PR China.
免疫检查点抑制剂 (ICI) 已经改变了先进的HPV相关癌症治疗,在化疗和TKI失败的情况下提供了生存益处. 结合ICI和贝瓦齐祖马布的联合治疗显示出延长整体存活时间的前景.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症研究 癌症研究
背景情况:
- 人类乳头瘤病毒 (HPV) 相关的癌症通常伴随着慢性炎症发展.
- 传统的治疗方法,如化疗和氨酸激酶抑制剂 (TKIs),在与HPV相关的晚期癌症中表现出有限的疗效.
- 瘤对全身疗法的耐药性需要新的治疗策略.
研究的目的:
- 审查免疫检查点抑制剂 (ICI) 治疗HPV相关癌症的历史发展和当前状态.
- 要总结最近的临床试验,涉及ICI在先进的HPV相关的癌症.
- 探索新兴的新型ICI,以实现未来的治疗进展.
主要方法:
- 临床试验的文献综述和对HPV相关癌症的ICI治疗的研究.
- 对治疗结果的分析,包括生存益处和耐药性模式.
- 讨论组合治疗方案,如ICI与贝瓦西祖马布.
主要成果:
- 包括抗CTLA-4和抗PD1/PDL1药物在内的ICI疗法在耐索拉芬尼布的患者中显示出生存益处.
- 结合治疗ICI与贝瓦齐祖马布已显著延长在先进的HPV相关的癌症后sorafenib的整体存活期 (OS).
- 最近的试验突出显示了ICI应用在这种患者群体中的不断变化的情况.
结论:
- 免疫检查点抑制剂代表了治疗先进的HPV相关癌症的范式转变.
- 优化的组合疗法对于最大限度地提高治疗效果和患者存活率至关重要.
- 对新型ICI的持续研究有可能为下一代检查点封锁疗法提供潜力.
更多相关视频
13:56A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
Published on: July 18, 2013
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
相关概念视频
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Tumor Immunotherapy
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...